Patent details

EP3000482 Title: DOUBLE-ACYLATED GLP-1 DERIVATIVES

Basic Information

Publication number:
EP3000482
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP151887312
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English Title of Invention:
DOUBLE-ACYLATED GLP-1 DERIVATIVES
French Title of Invention:
DERIVES GLP-1 DOUBLE-ACYLATES
German Title of Invention:
ZWEIFACH ACYLIERTE GLP-1-DERIVATE
SPC Number:

Dates

Filing date:
16/12/2010
Grant date:
21/04/2021
EP Publication Date:
30/03/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/04/2021
EP B1 Publication Date:
21/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/12/2021
Expiration date:
16/12/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/04/2021
 
 

Name:
Novo Nordisk A/S
Address:
Corporate Patents Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:
SPETZLER, Jane
Address:
Denmark (DK)

2

Name:
LINDEROTH, Lars
Address:
Denmark (DK)

3

Name:
LAU, Jesper
Address:
Denmark (DK)

4

Name:
GARIBAY, Patrick William
Address:
Denmark (DK)

5

Name:
KODRA, János Tibor
Address:
Denmark (DK)

6

Name:
SAUERBERG, Per
Address:
Denmark (DK)

Priority

1

Priority Number:
09179390
Priority Date:
16/12/2009
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
288601 P
Priority Date:
21/12/2009
Priority Country:
United States (US)

Classification

IPC classification:
C07D 233/64; C07K 14/605;

Publication

European Patent Bulletin

Issue number:
202116
Publication date:
21/04/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages